Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

« Older Entries
Newer Entries »

Peeks Social $PEEK.ca Completes Personas Acquisition $BCOV $AVID

Posted by AGORACOM-JC at 9:07 AM on Tuesday, May 8th, 2018

Peeks large

  • Acquisition of Personas.com Corporation has been completed pursuant to an amalgamation agreement between Peeks Social, a wholly-owned subsidiary of Peeks Social, Personas, Riavera Corp. and a wholly-owned subsidiary of Riavera

TORONTO, May 08, 2018 — Peeks Social Ltd. (TSXV:PEEK) (OTCQB:PKSLF) (“Peeks Social” or “the Company”) is pleased to report that further to its press release dated February 5, 2018, the acquisition of Personas.com Corporation (“Personas”) has been completed pursuant to an amalgamation agreement between Peeks Social, a wholly-owned subsidiary of Peeks Social (“Peeks Social Subco”), Personas, Riavera Corp. (“Riavera”), and a wholly-owned subsidiary of Riavera (“Riavera Subco”).  Articles of amalgamation to amalgamate Peeks Social Subco, Personas, and Riavera Subco were filed on May 2, 2018, resulting in the creation of a single wholly-owned subsidiary named Peeks Social Technologies Holding Inc. (the “Transaction”).

Shareholders of both Peeks Social and Personas overwhelmingly approved the Transaction as reported on April 19 and May 2, 2018. The closing of the Transaction has resulted in the acquisition of the technology assets of the Peeks Social livestreaming product and in the Company receiving 100% of the gross revenue generated by these assets.  Details of the Transaction can be found in the Company’s Information Circular dated March 19, 2018, as posted under the Company’s profile on SEDAR.

Prior to the Transaction, Personas was a private company controlled by Mr. Mark Itwaru, Chairman & CEO of the Company. Riavera is an existing “Control Person” of the Company within the meaning of the rules and policies of the TSX Venture Exchange, and is a significant shareholder of the Company and a related party to Personas prior to the Transaction. Collectively and immediately prior to the Transaction these parties owned an aggregate of 15,602,388 common shares of the Company, representing 24.0% of the issued and outstanding shares of the Company pre-Transaction (non-diluted).

To effect the Transaction the Company issued 175,150,454 common shares to the shareholders of Personas and Riavera Subco (including 61,340,322 issued to Mr. Mark Itwaru, 55,346,527 issued to Riavera, and 1,245,492 issued to certain directors and officers of the Company) on May 7, 2018, at a negotiated price of $0.7308 per share. The closing price of the Company’s common shares on the TSX Venture Exchange on May 7, 2018, was $0.395. The Company now has 240,126,725 issued and outstanding common shares.

Following the Transaction, Mr. Mark Itwaru and Riavera collectively own an aggregate of 132,289,237 common shares of the Company, representing 55% of the issued and outstanding common shares of the Company (non-diluted). This ownership position, being over 50% of the outstanding voting common shares, provides Mr. Itwaru with the sole ability to determine who is elected as directors of the Corporation. As a majority shareholder, there may be conflicts of interest that arise between Mr. Itwaru and the Corporation.

The Peeks Social app can be downloaded in either the Apple or Google app stores or by visiting www.peeks.social

For further information, please contact:

Peeks Social Ltd.
Mark Itwaru
Chairman & Chief Executive Officer
416-815-7000 x303
[email protected]

David Vinokurov
Director Investor Relations
416-716-9281
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this Release.

Tags: , ,
Posted in All Recent Posts, Peeks Social Ltd. | Comments Off on Peeks Social $PEEK.ca Completes Personas Acquisition $BCOV $AVID

Kuuhubb $KUU.ca Acquires Full Global Rights and Revenue to My Hospital Game $TCEHY $ATVI $CYOU

Posted by AGORACOM-JC at 9:04 AM on Tuesday, May 8th, 2018

  • Signed the definitive agreement for, and completed the acquisition of, the full global rights and revenue to the My Hospital game
  • Kuuhubb has purchased the full global rights and revenue to the My Hospital game for 2.6 million Euros, to be paid in monthly instalments between May 2019 and June 2021

TORONTO, May 08, 2018 – Kuuhubb Inc. (“Kuuhubb” or the “Company”) (TSX-V:KUU) announces that, further to its February 28, 2018 press release, it has signed the definitive agreement for, and completed the acquisition of, the full global rights and revenue to the My Hospital game.

Kuuhubb has purchased the full global rights and revenue to the My Hospital game for 2.6 million Euros, to be paid in monthly instalments between May 2019 and June 2021.  Additionally, after Kuuhubb has recouped the entire purchase price, Cherrypick Games is entitled to 25% net profit share.  Cherrypick Games will continue the current game development and update efforts until June 2021.

“We are delighted with the long-term potential of My Hospital.  The acquisition of My Hospital from Cherrypick Games is expected to provide Kuuhubb with cash flow and profitability as well as create long-term value through our expanding product portfolio globally,” commented Jouni Keränen, CEO of Kuuhubb.

About Kuuhubb
Kuuhubb is a company active in the digital space that focuses mainly on lifestyle and mobile video game applications. Its strategy is to create sustainable shareholder value through acquisitions of proven, yet underappreciated, assets with robust long-term growth potential. Headquartered in Helsinki, Finland, the Company has a global presence with a strong focus on developing U.S. brand collaborations and Asian partnerships.

Cautionary Note Concerning Forward-Looking Information
This press release contains forward-looking information.  All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements relating to the potential of My Hospital, future cash flow and profitability, growth of the Company’s business and expected benefits from the My Hospital acquisition) are forward-looking information. This forward-looking information reflects the current expectations or beliefs of the Company based on information currently available to the Company. Forward-looking information is subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking information, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on the Company.  Factors that could cause actual results or events to differ materially from current expectations include, among other things, risks related to the growth strategy of the Company, the possibility that results from the My Hospital acquisition will not be consistent with the Company’s expectations, the early stage of the Company’s development, competition from companies in a number of industries, the ability of the Company to manage expansion, future business development of the Company and the other risks disclosed under the heading “Risk Factors” in the Company’s annual information form dated October 30, 2017 filed on SEDAR at www.sedar.com.  Forward-looking information speaks only as of the date on which it is provided and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise.  Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Kuuhubb Inc.
Jouni Keränen – CEO
[email protected]
Office: +358 40 590 0919

Bill Mitoulas
Investor Relations
[email protected]
Office: +1 (416) 479-9547

Tags: , , , , ,
Posted in All Recent Posts, Kuuhubb | Comments Off on Kuuhubb $KUU.ca Acquires Full Global Rights and Revenue to My Hospital Game $TCEHY $ATVI $CYOU

FEATURE: Glacier Lake Resources Silver Vista Assays Pending $JAX.ca $AMI.ca $GTT.ca $HBM.ca

Posted by AGORACOM at 8:39 AM on Tuesday, May 8th, 2018

Developing Silver Vista Project into Bulk Tonnage Silver & Copper

  • Completed 2018 Phase 1 drill program
  • Seven holes, totalling 1,273 metres drilled
  • Silver Vista Project, a sediment hosted Cu & Ag deposit with potential to host bulk mineralization
  • Sediment-hosted copper deposits include some of the richest and larges deposits in the world
  • Soil Geo-Chem survey defined anomaly 2.0KM by 1.5KM named the “MR prospect area”
  • Drilling focused at “MR”
  • Drill program results expected within 2Q/2018

 

Glacier Lake Power Point

Tags: , , , , , , ,
Posted in All Recent Posts, Featured | Comments Off on FEATURE: Glacier Lake Resources Silver Vista Assays Pending $JAX.ca $AMI.ca $GTT.ca $HBM.ca

FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes at 0.62% Nickel, 0.33% Copper

Posted by AGORACOM-JC at 4:32 PM on Monday, May 7th, 2018

TN:CSE

Investment Highlights

  • Acquisition of Canadian Arrow Mines Limited includes two Ontario-based nickel-copper-(cobalt) properties
  • Canadian Arrow’s Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 20 percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property with drill program in progress
  • Strong management team with proven experience in advancing projects to production readiness and increasing shareholder value
  • Tightly held share structure with 50 percent owned by approximately 10 investors

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined.
  • Preliminary  Economic Assessment completed in   2008   and later updated returned robust project
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of
    copper credits.
  • Plans for Kenbridge include updating the 2008 PEA, advancing the project through to feasibility and exploring
    the open mineralization at depth

Tags: , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Tartisan Resources | Comments Off on FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes at 0.62% Nickel, 0.33% Copper

#Blockchain As An Application Platform $SX $SX.ca $IDK.ca #Blockstation $HIVE.ca $BLOC.ca $CODE.ca

Posted by AGORACOM-JC at 10:30 AM on Monday, May 7th, 2018
  • Many business use cases can be improved and/or solved by using distributed ledger technology
  • Can be used in many cases where trust services are needed by business applications
  • Can be utilized by using blockchain technology as an application platform to build the underlying trust infrastructure of the system

Issam (Sam) Andoni

Seasoned technologist and recognized expert in the field of IDM, Security and Access Management, and the use of PKI technology.

 Issam (Sam) Andoni , Forbes Councils

Shutterstock

Many business use cases can be improved and/or solved by using distributed ledger technology. It can be used in many cases where trust services are needed by business applications. This can be utilized by using blockchain technology as an application platform to build the underlying trust infrastructure of the system.

Although Bitcoin, the first real implementation of blockchain, is a decentralized currency and payment system, the underlying constructs that form the basis of the system do not have to be limited to payment transactions, accounts, balances or users. Instead, blockchain technology in Bitcoin is nothing more than transactions secured and executed by a scripting language using cryptographic methods. This means that blockchain is a platform with a scripting language that can solve many use cases other than just cryptocurrencies.

This property of blockchain led to smart contracts, an innovation presented by the cryptocurrency known as Ethereum. In the case of Ethereum, developers can create private cryptocurrencies and contract-based applications using a Turing-complete language, which allows businesses to use this language to set their own rules and policies in such applications.

The distributed ledger technology used in blockchain offers multiple benefits to businesses that make a difference when implementing a solution that requires a high degree of trust for business transactions. Using the technology offers the possibility to reduce costs and offers the opportunity for businesses to build and maintain an infrastructure that delivers capabilities at lower expenses than traditional centralized models.

Blockchain can process transactions faster because it doesn’t use a centralized infrastructure. Although there is no system totally secure from cyberattacks, the distributed nature of blockchain provides an unprecedented level of trust. The unchangeable property of blockchain and its public availability among its users, whether in a public ledger or a private one, provides transparency. Any user of the system can query transactions on a real-time basis.

Blockchain For Cryptocurrency

Bitcoin was the first implementation of a cryptocurrency based on distributed ledger technology. It was invented in 2009. and since then, it has been gaining popularity and traction by business owners seeking a distributed trust model. The Bitcoin consensus algorithm is based on proof of work (PoW). In PoW, transactions are collected into blocks by miners and added to the blockchain only if the miner can solve a cryptographic challenge that requires much computational power to be solved. The cryptographic challenge can only be solved by guessing, ensuring neutrality.

Other forms of proofs have been invented and incorporated into other solutions, such as the proof of stake in Ethereum and proof of elapsed time introduced by Intel.

Bitcoin and blockchain solved a very old digital currency problem that many other digital currencies tried to solve in the past known as the double spending problem. Double spending means spending the same digital currency twice, and Bitcoin solved this by ensuring distributed consensus.

Another cryptocurrency benefit that blockchain technology provides is that transfers can cross national boundaries in seconds, with minimum fees, and without going through third-party entities such as banks.

Read entire article here: https://www.forbes.com/sites/forbestechcouncil/2018/05/07/blockchain-as-an-application-platform/#e679c405576e

Tags: , , , ,
Posted in All Recent Posts, Blockchain stocks, Blockstation, Canadian Blockchain Stocks, Smallcap Blockchain stocks | Comments Off on #Blockchain As An Application Platform $SX $SX.ca $IDK.ca #Blockstation $HIVE.ca $BLOC.ca $CODE.ca

Namaste $N.ca $NXTTF Signs Exclusive Drop-Shipping Agreement With Ample Organics Enabling Ample’s Licensed Producer Customers to Sell Vaporizers and Accessories $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:49 AM on Monday, May 7th, 2018

  • Signed an exclusive drop-shipping supply agreement with Ample Organics Inc.
  • Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis
  • Namaste will connect its cannabis hardware and accessory platform via API integration with Ample Organics’ system

VANCOUVER, British Columbia, May 07, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed an exclusive drop-shipping supply agreement (the “Agreement”) with Ample Organics Inc. (“Ample Organics”). Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis (“LPs”). Under the terms of the Agreement, Namaste will connect its cannabis hardware and accessory platform via API integration with Ample Organics’ system. This will allow each of Ample Organics’ LP customers to have instant access to a large variety of devices and accessories available for purchase during checkout. The Agreement will provide added value for Ample Organics customers by offering their patients industry-leading products. Namaste is proud to have this unique opportunity in partnering with Canada’s most innovative seed-to-sale software company and this Agreement clearly demonstrates Namaste’s continued focus on achieving technological development for the cannabis industry.

Key Terms of the Agreement

  • Namaste will supply Ample Organics customers with access to the Company’s full range of vaporizers and accessories through an API integration, as the exclusive drop-shipping supplier to Ample Organics.
  • Namaste will have first right of refusal to supply new products as requested by Ample Organics, or its customers, for drop-shipping through the API integration.
  • In the event that Namaste decides not to carry a new product or cannot source such product within 30 days, Ample Organics will be granted the right to offer the new product using drop-shipping through a 3rd party supplier.
  • Each order will be submitted electronically via API integration that will also provide live access to tracking information, inventory and shipping data.
  • Namaste will be responsible, at its cost for all product support, returns and warranty claims.
  • Unless Namaste advises otherwise, solely due to pricing restrictions from the product manufacturers, Ample Organics and its customers shall agree to set the prices for the Products at a Minimum Advertised Price (MAP), to be specified by Namaste for each product.

Namaste’s partnership with Ample Organics represents a unique opportunity to provide virtually hundreds of thousands of medical cannabis patients with access to a variety of high-quality vaporizers, which research has shown is a far superior and healthier way to consume medical cannabis. This agreement further demonstrates Namaste’s commitment to the medical cannabis patients of Canada, and in ensuring that they have easy and affordable access to the best cannabis hardware products on the market.

The Agreement represents an important step for Namaste and is accretive in nature, as it will provide immediate, low-overhead revenue for both Namaste and Ample Organics. The Company will now focus its efforts on completing the integration with Ample Organics as soon as possible and will continue to explore further opportunities that have the potential to bring value to Namaste, its partners, and the entire cannabis market.

Management Commentary

John X. Prentice, President and CEO of Ample Organics comments; “This partnership represents a substantial value-add for Ample Organics’ clients and their patient customers. It will simplify inventory management and fulfillment for LPs, while ensuring that medical cannabis patients across the country have access to a substantial catalogue of vaporizers and cannabis accessories at great prices. We are excited to continue the development of our relationship with Namaste and look forward to advancing the industry in new and innovative ways together.”

Sean Dollinger, President and CEO of Namaste comments; “We are very proud to be partnered with Ample Organics on this project. It’s been very rewarding to collaborate with the management team, on what we believe is an important initiative for all those involved, most importantly of which are the medical cannabis patients of Canada. We are incredibly excited to be associated with Ample Organics and to have the opportunity to provide healthier, more affordable options for medical patients to consume cannabis. Our commitment to developing a platform with easily accessible products and services for the cannabis industry is what inspired the opportunity to work with Ample Organics. We’re looking forward to completing the integration and to further enhancing the patient experience.”

About Ample

Ample Organics is Canada’s leading cannabis business solution, adopted by 75% of the nation’s Licensed Producers. To date, the Ample Organics platform has processed more than 880,000 orders and 16,000,000 grams of cannabis. Ample Organics makes compliance easy by tracking individual plants from seed to consumer and reporting every detail of the growth, production, and sales processes. With Ample Organics, data is collected at the most granular levels, offering insights that can drive business decisions and help to protect public safety. Beyond seed to sale, Ample Organics’ extended suite of products creates a complete ecosystem for cannabis businesses. From easy patient registration to cannabis-exclusive payment solutions, Ample Organics continues to evolve and release new products to provide reliable and compliant solutions for the cannabis industry.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors,

Sean Dollinger
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com
namastevapes.ca
everyonedoesit.ca
namastevaporizers.co.uk
everyonedoesit.co.uk
australianvaporizers.com.au

For more information about Ample Organics, please visit ampleorganics.com or contact:
Peter Slater
VP, Corporate Development
Direct: +1 (416) 262-4175
Email: [email protected]

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Tags: , , , , ,
Posted in All Recent Posts, Featured, Namaste Technologies Inc. | Comments Off on Namaste $N.ca $NXTTF Signs Exclusive Drop-Shipping Agreement With Ample Organics Enabling Ample’s Licensed Producer Customers to Sell Vaporizers and Accessories $ACB.ca $HIP.ca $WEED.ca $CMED.ca

$GRAT.ca Gratomic Announces Successful Startup of Aukam Proccesing Plant

Posted by AGORACOM at 9:02 AM on Monday, May 7th, 2018

 

  • Aukam processing plant has been commissioned successfully
  • An initial shipment of graphite concentrate has been delivered
  • 4.5 tonnes of graphite concentrate grading between 88%-95% Carbon as Graphite delivered
  • Perpetuus Carbon Technologies will manufacture graphenes to be used in the tire industry.

TORONTO, May 07, 2018 (GLOBE NEWSWIRE) – Gratomic Inc. (“Gratomic” or the “Company”) (GRAT.V) (CB81.F) a vertically integrated graphite to graphenes, advanced materials development company is pleased to announce that its Aukam processing plant has been commissioned successfully and an initial shipment of graphite concentrate has been made.

The Aukam processing plant was constructed between December 2017 and March 2018, with initial throughput and optimization reached during March and April 2018. To date, the plant has generated 4.5 tonnes of graphite concentrate grading between 88%-95% Carbon as Graphite (“Cg”) of which 2.25 tonnes of concentrate has been shipped to Perpetuus Carbon Technologies (“Perpetuus”) for the manufacture of graphenes to be used in the automobile bicycle tire industry. Gratomic and Perpetuus are currently in collaboration to build on Perpetuus’ capability to initially provide 500 tonnes of surfaced modified graphenes per annum to support the volumes required by the tire manufacturing industry (see March, 4, 2018 news release). The first cycle tire order for the graphenes to a globally recognised brand is planned for delivery at the end of the second quarter of 2018. Additional applications that have now been generated in a preproduction format include radiant heating membranes and super hydrophobic coatings with an addressable market that includes: marine, oil & gas, power generation, industrial (repair & maintenance), infrastructure (new build) and automotive & transportation among others.

Gratomic’s CO-CEO Arno Brand stated, “The successful start-up of our Aukam processing plant is a major milestone for the Company, one that allows us to begin feeding concentrate to Perpetuus for the manufacturing of graphenes for use as a material enhancing filler within tire elastomers.”

The Aukam processing plant uses a simple crushing, grinding and flotation system with a current capacity of 600 tonnes per annum. Construction is already underway for the installation of a larger mill with a 10,000 tonne per annum capacity.

Graphite Feed for the Aukam processing plant is obtained from screening and sorting of stockpiles existing from historical and recent mining. An average feed grade of 56.29% Cg with a range of 41.55% Cg to 63.87% Cg was determined from ten, 2kg to 30kg, grab samples from across the stockpiled lumps (see June 3, 2016 and July 12, 2016 news releases). Note that assays of grab samples should not be taken as representative of the mineralization on the Aukam property as a whole.

The technical content of this News Release was reviewed and approved by Roger Moss Ph.D., P.Geo, a qualified person as defined by National Instrument 43-101.

About Gratomic Inc.
Gratomic is an advanced materials company focused on mine to market commercialization of graphite products most notably high value graphene-based components for a range of mass market products. We are collaborating with a leading European manufacturer of graphenes to use Aukam graphite to manufacture graphene products for commercialization on an industrial scale. The company is listed on the TSX Venture Exchange under the symbol GRAT.

For more information: visit the website at www.gratomic.ca or contact:

Arno Brand, Co-CEO, +1 416-561-4095

E-mail inquiries: [email protected]

“Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”

FORWARD LOOKING STATEMENTS: This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions.  Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in Canada (available at www.sedar.com).

Tags: , , , , , ,
Posted in AGORACOM News And Events, AGORACOM Small-Cap TV, All Recent Posts, Graphite, Small and Micro-Cap Space | Comments Off on $GRAT.ca Gratomic Announces Successful Startup of Aukam Proccesing Plant

FEATURE: Kuuhubb $KUU.ca Mobile Video Gaming And Apps For Women; $US 6.6M Quarterly Revenues, 33M Downloads, 7M Monthly Active Users $TCEHY $ATVI $CYOU

Posted by AGORACOM-JC at 3:21 PM on Friday, May 4th, 2018

Why Kuuhubb?

  • $US 6.6 Million Quarterly Revenues
  • 200 Million Quarterly Sessions
  • 33 Million Downloads
  • 7 Million Monthly Active Users (MAU)
  • Partnerships: Kellogg’s and Samsung
  • Research Reports Target Significantly Higher Prices (Please Refer To Echelon Wealth Partners and Cormark Securities)
  • Aggressive Global Growth Plans Now Underway
  • Japan Already Established. Japan Mobile Revenues
  • Have Surpassed The USA For 3 Consecutive Years
  • India, Korea and China Are Planned For 2018
  • Global Social App Comparables Are Trading At $58/Monthly Active User (MAU) (Excluding Facebook)

Tags: , , , , , , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Kuuhubb | Comments Off on FEATURE: Kuuhubb $KUU.ca Mobile Video Gaming And Apps For Women; $US 6.6M Quarterly Revenues, 33M Downloads, 7M Monthly Active Users $TCEHY $ATVI $CYOU

Tetra BioPharma $TBP.ca Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001 $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:24 AM on Friday, May 4th, 2018

Logo tetrabiopharma rgb web

  • Tetra Bio-Pharma Inc. and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for the marketing and distribution of PPP001 in Portugal
  • Binding term sheet will pave the way towards signing a Definitive Distribution Agreement.
  • Tetra is eligible to receive an upfront payment, milestone payments and will be paid a share of the profits generated by the sales of PPP001 in Portugal.
  • Azevedos will also be responsible for registering the product, as well as all marketing and distribution in Portugal

OTTAWA, May 04, 2018 – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for the marketing and distribution of PPP001 in Portugal. This binding term sheet will pave the way towards signing a Definitive Distribution Agreement.

Tetra is eligible to receive an upfront payment, milestone payments and will be paid a share of the profits generated by the sales of PPP001 in Portugal. Azevedos will also be responsible for registering the product, as well as all marketing and distribution in Portugal.

“We are honored to partner with Azevedos, a company established in 1775, rich in tradition, and a major player in the Portuguese pharmaceutical market. This Partnership deal provides Tetra with its foray into the European market.” stated Dr. Guy Chamberland M.Sc., Ph.D., Interim CEO and Chief Scientific Officer.

“These partnerships are very important for Azevedos Indústria Farmacêutica and mean that international entities recognize our history, values, work and our technology know-how. Although having a long past, Azevedos is a pharmaceutical company turned to the future and focused on new challenges”, says Thebar Miranda, CEO of Azevedos Indústria Farmaceutica, S.A.

About PPP001 
On April 4, 2018, Tetra officially started the Phase 3 trial for PPP001 indicated for terminal stage cancer patients with a goal to improving the quality of life of these patients as well as minimizing their pain. PPP001 is being developed to be the first smokable cannabis product for advanced cancer pain available under prescription.

About Azevedos Indústria Farmacêutica, S.A
Azevedos Group is a two-century Portuguese pharmaceutical brand, whose wide scope of activity ranges from development to distribution, leading manufacturing and exports to more than 60 regulated countries worldwide. Azevedos owns more than 300 MAs for the most relevant therapeutic areas covering all technology forms manufactured at its state of the art plant holding the most recognized certifications.

About Tetra Bio-Pharma: Tetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products. Tetra Bio-Pharma is currently developing a pipeline of five cannabinoid-based products using different delivery systems such as smokable pellets, oral tablets, eye drops and topical ointments.

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a license for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact:
Tetra Bio-Pharma Inc.
Dr Guy Chamberland, interim CEO and CSO
[email protected]
514-220-9225

Robert (Bob) Bechard, MBA, MSc., BA,
Vice-President Finance and Business Development
[email protected]
514-817-2514

For media information, please contact:
Daniel Granger
[email protected]
ACJ Communication
O: 1 514-840-7990 M: 1 514-232-1556

Tags: , , , ,
Posted in All Recent Posts | Comments Off on Tetra BioPharma $TBP.ca Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001 $AERO $CBDS $CGRW $APH.ca $GBLX

Marijuana Company of America’s $MCOA hempSMART(TM) Brand Engages Kim Castle and Verve Integrative to Manage Television Ad Campaign for Its CBD Product Line $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:12 AM on Friday, May 4th, 2018

15233 mcoa

  • Wholly owned subsidiary, H Smart, Inc. has engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television ad campaign to promote its hempSMART™ product line.
  • Budget for the DRTV program is approximately $100,000.

Escondido, California–(May 4, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary, H Smart, Inc. has engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television (DRTV) ad campaign to promote its hempSMART™ product line.

The Company anticipates that its recently announced EPCO direct sales marketing campaign, in conjunction with the upcoming DRTV marketing campaign and the Company’s ongoing network marketing campaign should result in an improvement in hempSMART™ product sales in Q3 and Q4 2018. The budget for the DRTV program is approximately $100,000.

hempSMART™ is working with Ms. Castle of Verve Integrative and their experienced marketing team to develop a market strategy and a television commercial for the hempSMART™ Pet Drops that will air on cable networks in select regions nationally this summer. The hempSMART™ commercial spot will have featured placement on the official eCommerce site of a well-known DRTV company and will be broadly promoted on integrated social media outlets, benefiting from well-established consumer engagement strategies.

Ms. Castle is leading a team that has more than 25 years of experience in many variations of media strategy, development and production, working for Disney, GM, ABC, Paramount, GreyGroup and McCann, to mention just a few. They specialize in multipoint story experiences designed to educate, entertain and endorse while mirroring the human mind’s process of solving a problem, thereby supporting consumers in making emotional and logical product conclusions. Ms. Castle’s experience both in front of and behind the camera provides an invaluable edge to the hempSMART™ marketing campaign.

In addition, Ms. Castle has personally been an advocate of CBD as an alternative to traditional products currently on the market. “We are very pleased to partner with hempSMART™ on their journey to bring such thoughtful and well-developed products to the people who need natural relief and enhanced health solutions. I wish hempSMART™ Pet Drops were available to support my cherished dog when we were going through a health challenge together,” said Castle.

Donald Steinberg, CEO of MCOA, stated “Kim’s experience gives us an excellent opportunity to greatly expand the marketing strategy for the hempSMART™ brand and product line. We are honored that the hempSMART™ product line will be managed by her and the Verve Integrative team. We look forward to the new television commercial airing this summer.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication, and disclaims CBD as a dietary supplement. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Tags: , ,
Posted in All Recent Posts, Marijuana Company of America, Medical Marijuana Stocks | Comments Off on Marijuana Company of America’s $MCOA hempSMART(TM) Brand Engages Kim Castle and Verve Integrative to Manage Television Ad Campaign for Its CBD Product Line $AERO $CBDS $CGRW $APH.ca $GBLX

« Older Entries
Newer Entries »